Written exposure therapy for posttraumatic stress symptoms and suicide risk: a randomized controlled trial with high-risk patients admitted to a military inpatient psychiatric unit

Abstract: Introduction: Active duty service members who are psychiatrically hospitalized for suicide are at the highest risk for suicide death following discharge. It is essential to test brief treatments that can be delivered during the short length of stay in inpatient psychiatry. Written Exposure Therapy, a brief treatment for posttraumatic stress disorder (PTSD), was augmented with Crisis Response Planning (WET + CRP) to address PTSD and suicidal ideation (SI). Methods: This randomized controlled trial evaluated the efficacy of the WET + CRP plus treatment as usual (n = 47; TAU) compared with TAU alone (n = 48) in reducing SI, PTSD symptoms, and rehospitalization among suicidal patients with at least moderate PTSD symptoms admitted to an inpatient psychiatric unit. PTSD symptoms and SI were assessed with clinician-administered interviews and self-report. Results: Participants were primarily male (61.1%) and active duty/reserve (93.7%). There were no significant group differences in clinician-assessed SI presence and PTSD symptom severity (the primary outcomes) or self-reported SI severity. WET + CRP demonstrated significant reductions in self-reported PTSD symptom severity compared with TAU; these reductions were the strongest during the month following discharge. Conclusions: Although the findings were not fully consistent with hypotheses, WET + CRP is feasible to deliver to suicidal, psychiatrically hospitalized service members and warrants additional study.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.